Author:
Schimmer Barbara,Nygard Karin,Eriksen Hanne-Merete,Lassen Jørgen,Lindstedt Bjørn-Arne,Brandal Lin T,Kapperud Georg,Aavitsland Preben
Abstract
Abstract
Background
On 20–21 February 2006, six cases of diarrhoea-associated haemolytic uraemic syndrome (HUS) were reported by paediatricians to the Norwegian Institute of Public Health. We initiated an investigation to identify the etiologic agent and determine the source of the outbreak in order to implement control measures.
Methods
A case was defined as a child with diarrhoea-associated HUS or any person with an infection with the outbreak strain of E. coli O103 (defined by the multi-locus variable number tandem repeats analysis (MLVA) profile) both with illness onset after January 1st 2006 in Norway. After initial hypotheses-generating interviews, we performed a case-control study with the first fifteen cases and three controls for each case matched by age, sex and municipality. Suspected food items were sampled, and any E. coli O103 strains were typed by MLVA.
Results
Between 20 February and 6 April 2006, 17 cases were identified, of which 10 children developed HUS, including one fatal case. After pilot interviews, a matched case-control study was performed indicating an association between a traditional cured sausage (odds ratio 19.4 (95% CI: 2.4–156)) and STEC infection. E. coli O103:H25 identical to the outbreak strain defined by MLVA profile was found in the product and traced back to contaminated mutton.
Conclusion
We report an outbreak caused by a rare STEC variant (O103:H25, stx
2-positive). More than half of the diagnosed patients developed HUS, indicating that the causative organism is particularly virulent. Small ruminants continue to be important reservoirs for human-pathogen STEC. Improved slaughtering hygiene and good manufacturing practices for cured sausage products are needed to minimise the possibility of STEC surviving through the entire sausage production process.
Publisher
Springer Science and Business Media LLC
Reference48 articles.
1. Tarr PI, Gordon CA, Chandler WL: Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet. 2005, 365: 1073-1086.
2. Johnson KE, Thorpe CM, Sears CL: The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli. Clin Infect Dis. 2006, 43: 1587-1595. 10.1086/509573.
3. Werber D, Behnke SC, Fruth A, Merle R, Menzler S, Glaser S, Kreienbrock L, Prager R, Tschape H, Roggentin P, Bockemuhl J, Ammon A: Shiga toxin-producing Escherichia coli infection in Germany: different risk factors for different age groups. Am J Epidemiol. 2007, 165: 425-434. 10.1093/aje/kwk023.
4. Grahek-Ogden D, Lassen J, Nygard K: EHEC infections in Norway 1995-2004 [In Norwegian]. MSIS-rapport. 2005, 38-
5. Lassen J, Heir E: Domestic outbreak of Enterohemorrhagic Escherichia coli (EHEC), summer 1999 [In Norwegian]. MSIS-rapport. 1999, 27-